Immatics N.V. (IMTX) vs Latigo Biotherapeutics Inc. (LTGO)

A side-by-side comparison of Immatics N.V. and Latigo Biotherapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

IMTX

Immatics N.V.

$1.04B

$7.76HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT

LTGO

Latigo Biotherapeutics Inc.

$1.01B

$16.74HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT

Total return — IMTX vs LTGO

growth of $100 · dividends reinvested · last 1y

IMTX -20.9% (-20.9%/yr)LTGO -7.6% (-7.6%/yr)LTGO compounded faster over this window

IMTX LTGO

Metrics side by side

Total return (annualized)

Metric	IMTX	LTGO
Total return (1Y)	-17.69%	N/A
Total return CAGR (3Y)	-7.35%	N/A
Total return CAGR (5Y)	-9.88%	N/A

LTGO is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full IMTX analysis Full LTGO analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.